Senzar Asset Management as of June 30, 2017
Portfolio Holdings for Senzar Asset Management
Senzar Asset Management holds 23 positions in its portfolio as reported in the June 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Halozyme Therapeutics (HALO) | 12.9 | $52M | 4.1M | 12.82 | |
| Express Scripts Holding | 10.1 | $41M | 641k | 63.86 | |
| Mylan Nv | 8.7 | $35M | 907k | 38.84 | |
| Neurocrine Biosciences (NBIX) | 8.5 | $35M | 749k | 46.00 | |
| Eli Lilly & Co. (LLY) | 8.4 | $34M | 415k | 82.30 | |
| Anthem (ELV) | 6.7 | $27M | 144k | 188.00 | |
| Gilead Sciences (GILD) | 6.5 | $27M | 374k | 70.79 | |
| Abbott Laboratories (ABT) | 5.4 | $22M | 451k | 48.61 | |
| Aerie Pharmaceuticals | 5.1 | $21M | 391k | 52.55 | |
| CVS Caremark Corporation (CVS) | 4.5 | $18M | 227k | 80.55 | |
| DaVita (DVA) | 4.1 | $17M | 259k | 64.84 | |
| Forward Pharma A/s | 3.3 | $13M | 653k | 20.33 | |
| Neuroderm Ltd F | 2.6 | $11M | 357k | 29.88 | |
| Tg Therapeutics (TGTX) | 2.4 | $9.7M | 969k | 10.05 | |
| LifePoint Hospitals | 2.2 | $9.0M | 134k | 67.19 | |
| Alder Biopharmaceuticals | 1.6 | $6.4M | 558k | 11.43 | |
| Corium Intl | 1.5 | $6.0M | 804k | 7.46 | |
| Concert Pharmaceuticals I equity | 1.4 | $5.8M | 412k | 13.98 | |
| Achillion Pharmaceuticals | 1.2 | $5.0M | 1.1M | 4.58 | |
| Retrophin | 1.2 | $4.8M | 246k | 19.32 | |
| Protagonist Therapeutics (PTGX) | 0.8 | $3.1M | 274k | 11.38 | |
| Foamix Pharmaceuticals | 0.7 | $2.6M | 569k | 4.62 | |
| Inotek Pharmaceuticals | 0.4 | $1.6M | 844k | 1.88 |
